|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
WHO004924932 |
| 003 |
DE-627 |
| 005 |
20230425172745.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210507s2020 xx |||||o 00| ||eng c |
| 035 |
|
|
|a (DE-627)WHO004924932
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)EUCTR2019-002396-34-FR
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)APHP180605
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Antibioprophylaxis for excision-graft surgery in burn patient: a multicenter randomized double-blind study
|b Antibioprophylaxis for excision-graft surgery in burn patient: a multicenter randomized double-blind study - A2B-trial
|
| 264 |
|
1 |
|c 2020
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 21-10-2019, Last updated: 2022-11-24
|
| 650 |
|
4 |
|a Medical Condition: excision-graft surgery in burn patient with a TBSA% between 5% and 40% MedDRA version: 22.0 Level: LLT Classification code 10006764 Term: Burn of unspecified site, unspecified degree System Organ Class: 100000004863 ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
|
| 650 |
|
4 |
|a Study Type: Interventional
|
| 650 |
|
4 |
|a Phase: Phase 3
|
| 650 |
|
4 |
|a Recruitment Status: Authorised-recruitment may be ongoing or finished
|
| 650 |
|
4 |
|a 610
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2020) vom: 01. Feb.
|
| 773 |
1 |
8 |
|g year:2020
|g day:01
|g month:02
|
| 856 |
4 |
0 |
|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002396-34
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2020
|b 01
|c 02
|
Klinische Studie